title: Early Cost-Effectiveness Modeling for Tumor Infiltrating Lymphocytes (TIL) -Treatment Versus Ipilimumab in Metastatic Melanoma Patients.
authors.affiliation: Netherlands Cancer Institute, Amsterdam, The Netherlands.
authors.forename: V P
authors.initials: VP
authors.lastname: Retèl
authors.affiliation: University of Twente, Enschede, The Netherlands.
authors.forename: L M G
authors.initials: LM
authors.lastname: Steuten
authors.affiliation: University of Twente, Enschede, The Netherlands.
authors.forename: J C
authors.initials: JC
authors.lastname: Mewes
authors.affiliation: University of Twente, Enschede, The Netherlands.
authors.forename: W H
authors.initials: WH
authors.lastname: van Harten